NIH-funded research R21 grant

Deciphering What Drives Juvenile Idiopathic Arthritis in African American Children

Official title: Deciphering Clinical and Genetic Determinants of Juvenile Idiopathic Arthritis in African American Children

Funded at Vanderbilt University Medical Center · NIH-11442239 · Data updated 2026-11-12

This project looks at why African American children with juvenile idiopathic arthritis have more joint damage, using clinical data and genetic information to find factors that may explain the differences.

More Arthritis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 15, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$409,063
NIH project number1R21AR088317-01
Project IDNIH-11442239 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children diagnosed with juvenile idiopathic arthritis, particularly those of African American descent, whose medical records and genetic data can be analyzed.

Less likely to help

Patients without JIA or those whose data do not contribute to the analyzed subgroups may not directly benefit.

What this research studies

Juvenile idiopathic arthritis (JIA) affects children and can lead to lasting joint damage. The study uses medical records and genetic data from diverse patients to identify risk factors that are linked to worse outcomes in Black children. By comparing clinical features and genetic patterns with other groups, the researchers hope to uncover why disease activity is higher in this population. The ultimate goal is to improve early identification and tailor treatments to reduce disability over time. The work builds on existing BioVU DNA biorepository data to explore connections between JIA, RA, and SLE features in African American patients.

Why it matters

Potential benefit: If successful, the work could lead to earlier risk detection and more personalized care to reduce joint damage in African American children with JIA.

How similar studies have gone: Preliminary analyses suggest meaningful associations between clinical/genetic factors and outcomes, supporting further investigation in this area.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Patrick, Anna Elizabeth — Vanderbilt University Medical Center
  • Study coordinator: Patrick, Anna Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.